Anticoagulant effect of Naja naja venom 5′nucleotidase: Demonstration through the use of novel specific inhibitor, vanillic acid

Toxicon

Volumn 48, Issue 4, 2006, Pages 411-421

  Dhananjaya, B L ^a   Nataraju, A ^a   Rajesh, R ^a   Raghavendra Gowda, C D ^a   Sharath, B K ^a   Vishwanath, B S ^a   D'Souza, Cletus J M ^a  

^a UNIVERSITY OF MYSORE   (India)

Author keywords

5 nucleotidase; Anticoagulant; Hemostasis; Naja naja; Vanillic acid

Indexed keywords

5' NUCLEOTIDASE; CONCANAVALIN A; PHOSPHOLIPASE A2; PROTEINASE; SNAKE VENOM; VANILLIC ACID;

ANTICOAGULATION; ARTICLE; BLOOD CLOTTING; ENZYME ACTIVITY; ENZYME INHIBITION; HEMOSTASIS; IN VITRO STUDY; PRIORITY JOURNAL;

5'-NUCLEOTIDASE; ANTICOAGULANTS; COBRA VENOMS; CONCANAVALIN A; DOSE-RESPONSE RELATIONSHIP, DRUG; ENZYME INHIBITORS; HEMOSTASIS; HUMANS; VANILLIC ACID;

NAJA NAJA;

EID: 33747761323     PISSN: 00410101     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.toxicon.2006.06.017     Document Type: Article

References (57)

1. Aird S.D. Ophidian envenomation strategies and the role of purines. Toxicon 40 (2002) 335-393
2. Avruch J., and Wallach D.F. Preparation and properties of plasma membrane and endoplasmic reticulum fragments from isolated rat fat cells. Biochim. Biophys. Acta 233 (1971) 334-347
3. 2) from the Indian cobra (Naja naja naja) venom. Biochem. Int. 25 (1991) 1023-1034
4. 2 from Indian cobra (Naja naja naja) venom. Toxicon 29 (1991) 1345-1349
5. Boffa M.C., and Boffa G.A. Correlations between the enzymatic activities and the factors active on blood coagulation and platelet aggregation from the venom of Vipera aspis. Biochim. Biophys. Acta 354 (1974) 275-290
6. Chen P.S., Toribara T.Y., and Warner H. Microdetermination of phosphorus. Anal. Chem. 28 (1956) 1756-1759
7. 2-induced oedema in rat paw. Eur. J. Pharmacol. 166 (1989) 505-510
8. 2. Thromb. Haemost. 49 (1983) 151
9. daSilva Jr. N.J., and Aird S.D. Prey specificity, comparative lethality and compositional differences of coral snake venoms. Comp. Biochem. Physiol. C 128 (2001) 425-456
10. Delaquis P., Stanich K., and Toivonen P. Effect of pH on the inhibition of Listeria spp. by vanillin and vanillic acid. J. Food Prot. 68 (2005) 1472-1476
11. Dimitrov G.D., and Kankonkar R.C. Fractionation of Vipera russelli venom by gel filtration. I. Toxicon 5 (1968) 213-221
12. Dirscherl W., and Wirtzfeld A. Vanillic acid in the human urine. Its isolation, determination and origin. Hoppe-Seyler's Z. Physiol. Chem. 336 (1964) 81-90
13. Erion M.D., van Poelje P.D., Dang Q., Kasibhatla S.R., Potter S.C., Reddy M.R., Reddy K.R., Jiang T., and Lipscomb W.N. MB06322 (CS-917): a potent and selective inhibitor of fructose 1, 6-bisphosphatase for controlling gluconeogenesis in type 2 diabetes. Proc. Natl. Acad. Sci. USA 102 (2005) 7970-7975
14. Ferry G., Ubeaud C., Mozo J., Pean C., Hennig P., Rodriguez M., Scoul C., Bonnaud A., Nosjean O., Galizzi J.P., Delagrange P., Renard P., Volland J.P., Yous S., Lesieur D., and Boutin J.A. New substrate analogues of human serotonin N-acetyltransferase produce in situ specific and potent inhibitors. Eur. J. Biochem. 271 (2004) 418-428
15. Francis B., Seebart C., and Kaiser I.I. Citrate is an endogenous inhibitor of snake venom enzymes by metal-ion chelation. Toxicon 30 (1992) 1239-1246
16. Gowda D.C., Jackson C.M., Hensley P., and Davidson E.A. Factor X-activating glycoprotein of Russell's viper venom. J. Biol. Chem. 269 (1994) 10644-10650
17. Hutton R.A., and Warrell D.A. Action of snake venom components on the haemostatic system. Blood Rev. 7 (1993) 176-189
18. Jagadeesha D.K., Shashidharamurthy R., Girish K.S., and Kemparaju K. A non-toxic anticoagulant metalloprotease: purification and characterization from Indian cobra (Naja naja naja) venom. Toxicon 40 (2002) 667-675
19. Jayaraman G., Krishnaswamy T., Kumar S., and Yu C. Binding of nucleotide triphosphates to cardiotoxin analogue II from the Taiwan cobra venom (Naja naja atra). Elucidation of the structural interactions in the dATP-cardiotoxin analogue ii complex. J. Biol. Chem. 274 (1999) 17869-17875
20. 2 enzymes from snake venoms. Toxicon 45 (2005) 1147-1161
21. Kini R.M., and Chow G. Exogenous inhibitors of platelet aggregation from animal sources. Thromb. Haemost. 85 (2001) 179-181
22. Kini R.M., and Evans H.J. Effects of snake venom proteins on blood platelets. Toxicon 28 (1990) 1387-1422
23. Kini R.M., Rao V.S., and Joseph J.S. Procoagulant proteins from snake venoms. Haemostasis 31 (2002) 218-224
24. Lazarovici P., and Lelkes P.I. Pardaxin induces exocytosis in bovine adrenal medullary chromaffin cells independent of calcium. J. Pharmacol. Exp. Ther. 263 (1992) 1317-1326
25. Lee W.-H., Zhang Y., Wang W.-Y., Xiong Y.-L., and Gao R. Isolation and properties of a blood coagulation factor X activator from the venom of king cobra (Ophiophagus hannah). Toxicon 33 (1995) 1263-1276
26. Li K., Chen X., Jia Y., and Bi K. Reverse-phase HPLC determination and pharmacokinetic study of vanillic acid in the plasma of rats treated with the traditional Chinese medicinal preparation Di-Gu-Pi decoction. Yakugaku Zasshi 124 (2004) 465-468
27. Lo T.B., Chen Y.H., and Lee C.Y. Chemical studies of Formosan cobra (Naja naja atra) venom (I). Chromatographic separation of crude venom, CM-Sephadex and preliminary characterization of its components. J. Chin. Chem. Soc. 13 (1966) 25-37
28. Lowry O.H., Rosebrough N.J., Farr A.L., and Randall R.J. Protein measurement with the Folin phenol reagent. J. Biol. Chem. 193 (1951) 265-275
29. Mannherz H.G., and Magener M. Concanavalin A inhibits the interaction of snake venom 5′nucleotidase and actin. FEBS Lett. 103 (1979) 77-80
30. Markland F.S. Snake venoms. Drugs 54 (1997) 1-10
31. Markland F.S. Snake venoms and the hemostatic system. Toxicon 36 (1998) 1749-1800
32. Mors W.B., Nascimento M.C., Pereira B.M., and Pereira N.A. Plant natural products active against snake bite-the molecular approach. Phytochemistry 55 (2000) 627-642
33. Murata J., Satake M., and Suzuki T. Studies on snake venom XII. Distribution of proteinase activities among Japanese and Formosan snake venoms. J. Biochem. 53 (1963) 431-443
34. Nikandrov N.N., Deshimaru M., Tani A., Chijiwa T., Shibata H., Chang C.C., Fukumaki Y., Ito T., and Ohno M. Purification, primary structures and evolution of coagulant proteases from Deinagkistrodon actus venom. Toxicon 46 (2005) 907-917
35. Okonogi T., Hattori Z., Ogiso A., and Mitsui S. Detoxification by persimmon tannin of snake venoms and bacterial toxins. Toxicon 17 (1979) 524-527
36. Ouyang C., and Huang T.F. Inhibition of platelet aggregation by 5′-nucleotidase purified from Trimeresurus gramineus snake venom. Toxicon 21 (1983) 491-501
37. Ouyang C., and Teng C.M. Fibrinogenolytic enzymes of Trimeresurus mucrosquamatus venom. Biochim. Biophys. Acta 420 (1976) 298-308
38. Pithayanakul P., Laovachirasuwan S., Bavovada R., Pakmanee N., and Suttisri R. Anti-venom potential of butanolic extract of Eclipta prostrata against Malayan pit viper venom. J. Ethnopharmacol. 90 (2004) 347-352
39. Reissig J.L., Stominger J.L., and Leloir L.F. A modified colorimetric method for the estimation of N-acetylamino sugars. J. Biol. Chem. 217 (1955) 959-969
40. Rossomando E.F., Cordis G.A., and Markham G.D. 5′-deoxy-5′-thioanalogs of adenosine and inosine 5′-monophosphate: studies with 5′-nucleotidase and alkaline phosphatase. Arch. Biochem. Biophys. 220 (1983) 71-78
41. 2 from Indian cobra (Naja naja naja) venom. Toxicon 36 (1998) 921-932
42. Sakurai Y., Shima M., Matsumoto T., Takatsuka H., Nishiya K., Kasuda S., Fujimura Y., and Yoshioka A. Anticoagulant activity of M-LAO, l-amino acid oxidase purified from Agkistrodon halys blomhoffii, through selective inhibition of factor IX. Biochim. Biophys. Acta 1649 (2005) 51-57
43. Shashidharamurthy R., Jagadeesha D.K., Girish K.S., and Kemparaju K. Variation in biochemical and pharmacological properties of Indian cobra (Naja naja naja) venom due to geographical distribution. Mol. Cell. Biochem. 229 (2002) 93-101
44. Singh M., Tiwari V., Jain A., and Ghoshal S. Protective activity of picroliv on hepatic amoebiasis associated with carbon tetrachloride toxicity. Indian J. Med. Res. 121 (2005) 676-682
45. Soares A.M., Ticli T.K., Marcussi S., Lourenco M.V., Januario A.H., Sampaio S.V., Giglio J.R., Lomonte B., and Pereira P.S. Medicinal plants with inhibitory properties against snake venoms. Curr. Med. Chem. 12 (2005) 2625-2641
46. Stefanovic V., Mandel P., and Rosenberg A. Concanavalin A inhibition of ecto-5′-nucleotidase of intact cultured C6 glioma cells. J. Biol. Chem. 250 (1975) 7081-7083
47. 2 from Naja nigricollis venom inhibits the prothrombinase complex by a novel nonenzymatic mechanism. Biochemistry 29 (1990) 7742-7746
48. Sundell I.B., Ranby M., Zuzel M., Robinson K.A., and Theakston R.D. In vitro procoagulant and anticoagulant properties of Naja naja naja venom. Toxicon 42 (2003) 239-247
49. Toukairin T., Uchino K., Iwamoto M., Murakami S., Tatebayashi T., Ogawara H., and Tonosaki Y. New polyphenolic 5′-nucleotidase inhibitors isolated from the wine grape "Koshu" and their biological effects. Chem. Pharm. Bull. 39 (1991) 1480-1483
50. Uchino K., Ogawara H., Akiyama T., and Fukuchi A. 5′-Nucleotidase inhibitory activity of nucleoticidin, melanocidin A and melanocidin. B. Structure-activity relationships. J. Antibiot. 38 (1985) 1564-1567
51. Varma R.S., Shukla A., and Chatterjee R.K. Evaluation of vanillic acid analogues as a new class of antifilarial agents. Indian J. Exp. Biol. 31 (1993) 819-821
52. 2. Eur. J. Biochem. 112 (1980) 25-32
53. 2 enzymes from habu (Trimeresurus flavoviridis) venom and their interaction with the alkaloid aristolochic acid. Toxicon 25 (1987) 501-515
54. 2 activity in rats. J. Clin. Invest. 92 (1993) 1974-1980
55. White J. Elapid snakes. In: Dart R. (Ed). Medical Toxicology (2004), Williams and Wilkins, Lippincott 1566-1578
56. White J. Snake venoms and coagulopathy. Toxicon 45 (2005) 951-967
57. Worthington Enzyme Manual, 1977. l-Amino acid oxidase. Worthington Biochemical Corporation, USA, pp. 49-50.